Open access
Oct 2026
Real-World Use of Dostarlimab in Endometrial Cancer: A Portuguese Multicenter Study.
INTRODUCTION Dostarlimab has been available in Portugal for advanced or recurrent endometrial cancer post-platinum therapy via an early access program (EAP) since November 2021, with reimbursement from October 2024; its use with carboplatin and paclitaxel was authorized under an early access program in June 2024. The a...
Margarida Quinto Pereira, Pedro Antunes-Meireles, A. R. Lopes et al.
· Acta Médica Portuguesa · 0 citations